Financial statements Ikar Apteka

Balance sheet of Ikar Apteka

Company age:
Age:
10 y. 2 m. 3 d.
Share capital:
Share capital:
5 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of IKAR APTEKA

Year
2018
2020
2021
2022
2023
Total assets 924 463,13 771 225,96 938 909,84 1 294 592,52 1 411 182,75
A. Fixed assets 191 599,71 159 388,05 135 301,33 115 183,73 18 460,08
B. Current assets 732 863,42 611 837,91 803 608,51 1 179 408,79 1 392 722,67
C. Share capital contributions (basic funds) - - - - -
D. Own shares (stocks) - - - - -
Total liabilities 924 463,13 771 225,96 938 909,84 1 294 592,52 1 411 182,75
A. Equity 209 921,29 142 223,47 196 785,14 348 330,11 362 633,14
B. Liabilities and provisions for liabilities 714 541,84 629 002,49 742 124,70 946 262,41 1 048 549,61
I. Long-term liabilities - - - - -
II. Short-term liabilities 669 099,41 586 861,45 701 894,65 880 981,11 990 026,83
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.